lecanemab

Lilly’s donanemab could bring new hope to Alzheimer’s patients in Australia following lecanemab rejection: GlobalData

Read more

Alzheimer’s drug Leqembi launched by Eisai, Biogen in China

Read more

Eisai submits MAA for lecanemab in Great Britain to treat early Alzheimer’s disease

Read more

Eisai files for approval of Alzheimer’s drug in Japan

Read more

Eisai files for approval of Alzheimer’s drug in Europe

Read more